Cross-sectional survey reveals treatment preferences in mild-to-moderate atopic dermatitis, suggesting implications for patient-centered care.
Key Points
This study aims to understand patient preferences regarding treatments for mild-to-moderate atopic dermatitis.
Conducted a cross-sectional web-based discrete choice experiment (DCE) survey with 300 adults diagnosed with mild-to-moderate AD.
Evaluated treatment profiles based on efficacy, risk, and administration frequency through DCE.
Analyzed data using a random parameters logit model and performed subgroup analysis to explore preference variability.
Achieving clear or almost clear skin within 3-4 months was the most valued treatment attribute.
Participants preferred a topical cream applied twice daily over systemic treatments.
Those with lower self-assessed disease burden favored topical treatments and were less risk-averse to potential side effects than those with higher burden.